Penumbra (PEN) Other financing activities (2014 - 2025)
Penumbra's (PEN) quarterly Other financing activities came in at $7.5 million in Q4 2025, up 184.53% year-on-year from $2.7 million in Q4 2024, and down 17.32% on a QoQ basis from $9.1 million in Q3 2025.
Penumbra (PEN) Other financing activities (2014 - 2025) Analysis & Trends
Penumbra (PEN) has 12 years of Other financing activities data on file, last reported at $7.5 million in Q4 2025.
- On a quarterly basis, Other financing activities rose 184.53% year-over-year to $7.5 million in Q4 2025; TTM through Mar 2026 was $12.4 million, a 207.96% increase from a year earlier, with the FY2025 full-year figure at $16.4 million, up 26998.36% from the prior year.
- Other financing activities for Q4 2025 stood at $7.5 million, down from $9.1 million in the prior quarter.
- Over the last five years, Other financing activities for PEN reached as high as $13.9 million in Q4 2022 and fell as low as -$8.9 million in Q4 2024.
- Historically, Other financing activities has averaged $2.4 million across 5 years, with a median of $939500.0 in 2021.
- Across the five-year window, Other financing activities slumped 770.65% in 2022 and soared 6693.44% in 2025, its largest moves.
- Year by year, Other financing activities stood at $11.5 million in 2021, then advanced by 20.75% to $13.9 million in 2022, then tumbled by 134.61% to -$4.8 million in 2023, then sank by 85.41% to -$8.9 million in 2024, then soared by 184.53% to $7.5 million in 2025.
- Per Business Quant data, the three most recent Other financing activities figures were $7.5 million in Q4 2025, $9.1 million in Q3 2025, and -$4.3 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Penumbra | 12.48 Bn | 11.87 Bn | 253.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7.54 Mn |
| Dec 31, 2025 | 7.54 Mn |
| Sep 30, 2025 | 9.12 Mn |
| Sep 30, 2025 | 9.12 Mn |
| Jun 30, 2025 | -4.28 Mn |
| Jun 30, 2025 | -4.28 Mn |
| Mar 31, 2025 | 4.02 Mn |
| Mar 31, 2025 | 4.02 Mn |
| Dec 31, 2024 | -8.92 Mn |
| Dec 31, 2024 | -8.92 Mn |
| Sep 30, 2024 | 8.92 Mn |
| Sep 30, 2024 | 8.92 Mn |
| Mar 31, 2024 | -61,000.00 |
| Mar 31, 2024 | -61,000.00 |
| Dec 31, 2023 | -4.81 Mn |
| Dec 31, 2023 | -4.81 Mn |
| Sep 30, 2023 | 4.81 Mn |
| Sep 30, 2023 | 4.81 Mn |
| Mar 31, 2023 | -155,000.00 |
| Mar 31, 2023 | -155,000.00 |